Uniplan Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.34M | Sell |
18,015
-10,080
| -36% | -$1.87M | 0.34% | 77 |
|
2025
Q1 | $5.89M | Sell |
28,095
-1,170
| -4% | -$245K | 0.57% | 48 |
|
2024
Q4 | $5.2M | Sell |
29,265
-21,174
| -42% | -$3.76M | 0.48% | 55 |
|
2024
Q3 | $9.96M | Sell |
50,439
-3,072
| -6% | -$607K | 0.87% | 30 |
|
2024
Q2 | $9.18M | Sell |
53,511
-954
| -2% | -$164K | 0.83% | 32 |
|
2024
Q1 | $9.92M | Sell |
54,465
-8,875
| -14% | -$1.62M | 0.78% | 34 |
|
2023
Q4 | $9.8M | Sell |
63,340
-4,462
| -7% | -$690K | 0.73% | 34 |
|
2023
Q3 | $9.13M | Hold |
67,802
| – | – | 0.7% | 41 |
|
2023
Q2 | $9.13M | Sell |
67,802
-1,551
| -2% | -$209K | 0.66% | 42 |
|
2023
Q1 | $11.1M | Sell |
69,353
-225
| -0.3% | -$35.9K | 0.78% | 35 |
|
2022
Q4 | $11.2M | Buy |
69,578
+5,699
| +9% | +$921K | 0.8% | 33 |
|
2022
Q3 | $8.57M | Buy |
63,879
+1,513
| +2% | +$203K | 0.66% | 39 |
|
2022
Q2 | $9.55M | Buy |
62,366
+4,807
| +8% | +$736K | 0.67% | 37 |
|
2022
Q1 | $9.33M | Sell |
57,559
-499
| -0.9% | -$80.9K | 0.55% | 41 |
|
2021
Q4 | $7.86M | Sell |
58,058
-2,498
| -4% | -$338K | 0.44% | 44 |
|
2021
Q3 | $6.53M | Sell |
60,556
-301
| -0.5% | -$32.5K | 0.4% | 50 |
|
2021
Q2 | $6.85M | Sell |
60,857
-4,076
| -6% | -$459K | 0.4% | 47 |
|
2021
Q1 | $7.03M | Sell |
64,933
-5,135
| -7% | -$556K | 0.45% | 47 |
|
2020
Q4 | $7.51M | Sell |
70,068
-8,942
| -11% | -$958K | 0.51% | 45 |
|
2020
Q3 | $6.92M | Sell |
79,010
-5,357
| -6% | -$469K | 0.48% | 46 |
|
2020
Q2 | $8.28M | Sell |
84,367
-11,271
| -12% | -$1.11M | 0.58% | 41 |
|
2020
Q1 | $7.29M | Buy |
95,638
+6,183
| +7% | +$471K | 0.55% | 43 |
|
2019
Q4 | $7.92M | Sell |
89,455
-5,991
| -6% | -$530K | 0.47% | 52 |
|
2019
Q3 | $7.23M | Buy |
+95,446
| New | +$7.23M | 0.45% | 50 |
|